Abstract Search

ea0032p145 | Calcium and Vitamin D metabolism | ECE2013

Experience in the treatment of primary hyperparathyroidism with cinacalcet: data after 12 months of treatment

Luque-Fernandez Ines , Garcia-Martin Antonia , Luque-Pazos Alessandra , Sastre-Marcos Julia , Vicente-Delgado Almudena , Marco-Martinez Amparo , Canovas Barbara

Introduction: Cinacalcet is an oral calcimimetic indicated in treatment of primary hyperparathyroidism if patients do not accept surgery, do not carry out the surgical criteria, there is failure of previous surgery or serious comorbidity that makes surgery impossible.Methods: Descriptive study that included 20 patients with primary hyperparathyroidism who had complete at least 12 months of treatment with cinacalcet for different reasons (eight patients r...

0 shares

ea0041gp97 | Diabetes (2) | ECE2016

Real-world comparative effectiveness of liraglutide, exenatide once weekly and lisixenatide in patients with type 2 diabetes mellitus

Marco Martinez Amparo , Martinez Garcia Ana , Herranz Antolin Sandra , Lopez Gallardo Gemma , Jose Pines Corrales Pedro , Quilez Toboso Rosa , Aguirre Sanchez-Covisa Miguel , Joaquin Alfaro Jose

The improvement of glycemic control and body weight reduction by GLP-1 receptor agonist (GLP1RA) has been demostred in randomized clinical trials, but comparative studies of the efficacy of different GLP1RA in real world and clinical practice setting are limited.Objectives: To compare the efficacy of liraglutide (LIRA), exenatide once weekly (EQW), and lisixenatide (LIXI) treatment in a real-world and clinical practice setting.Meth...

0 shares

ePoster

Endocrine Abstracts

Experience in the treatment of primary hyperparathyroidism with cinacalcet: data after 12 months of treatment

Real-world comparative effectiveness of liraglutide, exenatide once weekly and lisixenatide in patients with type 2 diabetes mellitus

BiosciAbstracts